Bart van Osch is a member of the 2022 Expert Review Committee for the Generic & Biosimilar Medicines Programme. Bart has been Director of Quality Affairs at the IDA Foundation since 2021, responsible for QA management in compliance with Dutch regulatory and other relevant regulations, while respecting IDA’s mission statement to provide access to medicines and medical goods to countries in need. Bart directs and manages QA departments considering priorities and lead-times, performs audits on compliance to ISO 13485 and good manufacturing practice, and provides guidance on quality matters and compliance externally and internally.
Prior to joining the IDA, Bart worked in the pharmaceutical industry for more than 20 years, primarily with MSD (Merck Sharp & Dohme) in a range of QA roles. In 2019, Bart was involved for four weeks as a trainer and mentor in the STEP programme, a GAVI initiative to enhance local senior management skills for an immunization programme in Ghana.
Bart completed a full Pharmacy course, including a postgraduate for a registered pharmacist, at the University of Groningen.